ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 197 filers reported holding ALKERMES PLC in Q1 2021. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,089,234 | -4.4% | 217,395 | +6.9% | 0.00% | +33.3% |
| Q2 2023 | $6,367,985 | -6.7% | 203,450 | -16.0% | 0.00% | -25.0% |
| Q1 2023 | $6,827,111 | +19.8% | 242,182 | +11.0% | 0.00% | +33.3% |
| Q4 2022 | $5,699,005 | +25.1% | 218,102 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $4,557,000 | +62.1% | 204,066 | +116.2% | 0.00% | +50.0% |
| Q2 2022 | $2,811,000 | +0.2% | 94,368 | -11.4% | 0.00% | +100.0% |
| Q1 2022 | $2,804,000 | +5.0% | 106,563 | -7.2% | 0.00% | 0.0% |
| Q4 2021 | $2,671,000 | -42.9% | 114,854 | -24.3% | 0.00% | -50.0% |
| Q3 2021 | $4,678,000 | -9.1% | 151,677 | -27.8% | 0.00% | -33.3% |
| Q2 2021 | $5,148,000 | +1633.3% | 209,944 | +1218.3% | 0.00% | – |
| Q1 2021 | $297,000 | -16.6% | 15,925 | -10.8% | 0.00% | – |
| Q4 2020 | $356,000 | +20.7% | 17,848 | +0.5% | 0.00% | – |
| Q3 2020 | $295,000 | -40.6% | 17,751 | -30.7% | 0.00% | – |
| Q2 2020 | $497,000 | -92.9% | 25,612 | -94.7% | 0.00% | -100.0% |
| Q1 2020 | $7,020,000 | -53.2% | 486,835 | -33.8% | 0.01% | -40.0% |
| Q4 2019 | $14,996,000 | -8.3% | 735,180 | -12.3% | 0.01% | -9.1% |
| Q3 2019 | $16,356,000 | -48.6% | 838,409 | -40.6% | 0.01% | -42.1% |
| Q2 2019 | $31,821,000 | -12.7% | 1,411,930 | +41.4% | 0.02% | -13.6% |
| Q1 2019 | $36,437,000 | +54.6% | 998,627 | +25.0% | 0.02% | +29.4% |
| Q4 2018 | $23,570,000 | -46.1% | 798,796 | -22.5% | 0.02% | +30.8% |
| Q3 2018 | $43,731,000 | -19.7% | 1,030,499 | -22.1% | 0.01% | -13.3% |
| Q2 2018 | $54,432,000 | +87.5% | 1,322,490 | +164.1% | 0.02% | +7.1% |
| Q1 2018 | $29,024,000 | +89.1% | 500,828 | +78.5% | 0.01% | +40.0% |
| Q4 2017 | $15,351,000 | -14.4% | 280,561 | -20.5% | 0.01% | -16.7% |
| Q3 2017 | $17,935,000 | -27.4% | 352,856 | -17.2% | 0.01% | -33.3% |
| Q2 2017 | $24,710,000 | -1.9% | 426,283 | -1.0% | 0.02% | -5.3% |
| Q1 2017 | $25,196,000 | -11.0% | 430,738 | -15.5% | 0.02% | -17.4% |
| Q4 2016 | $28,325,000 | -2.4% | 509,663 | -17.4% | 0.02% | +9.5% |
| Q3 2016 | $29,013,000 | -13.5% | 616,970 | -20.5% | 0.02% | -12.5% |
| Q2 2016 | $33,537,000 | +93.7% | 776,005 | +53.2% | 0.02% | +84.6% |
| Q1 2016 | $17,313,000 | -79.1% | 506,487 | -51.5% | 0.01% | -77.2% |
| Q4 2015 | $82,949,000 | -9.2% | 1,044,989 | -32.9% | 0.06% | -19.7% |
| Q3 2015 | $91,307,000 | -3.7% | 1,556,373 | +5.6% | 0.07% | +16.4% |
| Q2 2015 | $94,800,000 | +5.9% | 1,473,467 | +0.4% | 0.06% | +8.9% |
| Q1 2015 | $89,512,000 | +29.3% | 1,468,182 | +24.2% | 0.06% | +30.2% |
| Q4 2014 | $69,246,000 | +56.1% | 1,182,511 | +14.3% | 0.04% | +53.6% |
| Q3 2014 | $44,360,000 | +2.8% | 1,034,832 | +20.6% | 0.03% | -3.4% |
| Q2 2014 | $43,169,000 | +119.1% | 857,748 | +92.0% | 0.03% | +107.1% |
| Q1 2014 | $19,700,000 | -5.6% | 446,846 | -13.0% | 0.01% | -6.7% |
| Q4 2013 | $20,872,000 | -21.5% | 513,703 | -35.0% | 0.02% | -25.0% |
| Q3 2013 | $26,587,000 | – | 790,872 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |